-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$12.8843.91% Upside
NeuroPace, Inc. Frequently Asked Questions
-
What analysts cover NeuroPace, Inc.?
NeuroPace, Inc. has been rated by research analysts at Wells Fargo, Lake Street, Cantor Fitzgerald, Morgan Stanley in the past 90 days.